Melanie Aganon is a pharmacist who is specialized in Ambulatory Care in Dunedin, Florida. Patients can reach her at 601 Main St, Dunedin or contact her on 727-734-6459. Active license number of Melanie Aganon is PS48002 for Ambulatory Care in Florida. Melanie Aganon is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Melanie Aganon speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Melanie Aganon
Specialization:
Ambulatory Care
Gender:
Female
Location:
601 Main St, Dunedin, Florida, 34698-5848
Phone:
727-734-6459
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Melanie Aganon are as mentioned below.
NPI Number:
1184430944
NPI Enumeration Date:
06 Dec, 2024
NPI Last Update On:
06 Dec, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Melanie Aganon are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
PS48002
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
601 Main St, Dunedin, Florida
Zip:
34698-5848
Phone Number:
--
Fax Number:
--
Patients can reach Melanie Aganon at 601 Main St, Dunedin, Florida or can call on phone at 727-734-6459.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.